亚洲社会药学

• 论文 • 上一篇    下一篇

Research on Acquiring Data for Pharmacoeconomic Evaluation

Duan Xiaomin, Lu Yan, Sun Lihua*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 出版日期:2016-12-20 发布日期:2017-02-08

Research on Acquiring Data for Pharmacoeconomic Evaluation

Duan Xiaomin, Lu Yan, Sun Lihua*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2016-12-20 Published:2017-02-08
  • Contact: Sun Lihua, professor. Major research area: pharmacoeconomics, medical investment performance and management, etc. Tel: 024-23986553, E-mail: slh-3632@163.com.

摘要: Objective To improve the methods for acquiring data for pharmacoeconomic evaluation at a low-cost in Liaoning Shenyang. Methods Literature review and field survey were used to analyze the problems in the current data accumulation in Shenyang. Results and Conclusion The sources of data mainly come from medical records, health files and medical insurance database as the retrospective methods. Three databases collect enough data for pharmacoeconomic evaluation, but there are still some problems. Suggestions are raised to strengthen the management of the medical records in hospitals and community to ensure that the records are complete, standardized and authentic. The management of adverse drug reaction records should be strengthened. Medical insurance data should be improved and standardized by learning the successful experience of other countries and regions.

关键词: data acquisition, data utilization, retrospective study, pharmacoeconomic evaluation

Abstract: Objective To improve the methods for acquiring data for pharmacoeconomic evaluation at a low-cost in Liaoning Shenyang. Methods Literature review and field survey were used to analyze the problems in the current data accumulation in Shenyang. Results and Conclusion The sources of data mainly come from medical records, health files and medical insurance database as the retrospective methods. Three databases collect enough data for pharmacoeconomic evaluation, but there are still some problems. Suggestions are raised to strengthen the management of the medical records in hospitals and community to ensure that the records are complete, standardized and authentic. The management of adverse drug reaction records should be strengthened. Medical insurance data should be improved and standardized by learning the successful experience of other countries and regions.

Key words: data acquisition, data utilization, retrospective study, pharmacoeconomic evaluation